SmartTots announces Lena Sun, MD and Jeffrey William Sall, PhD, MD as the recipients of its 2013/2014 round of pediatric anesthesia research grants. The research grants are intended to support investigations into the existence of a clinical signal suggesting poor neurocognitive outcomes as the result of early exposure to anesthesia. Drs. Sun and Sall will be conducting separate studies both centered around determining the effects of anesthetics on early brain development and each will receive $200,000 paid over a two-year period to fund their studies.
Millions of children receive anesthesia each year. Non‐clinical studies in juvenile animal models show that exposure to some anesthetics and sedatives is associated with memory and learning deficits and other neurodegenerative changes in the central nervous system. Insufficient human data exist to support or refute the possibility that similar effects occur in children. SmartTots is dedicated to funding research that will help determine if any particular anesthetic or sedative drugs pose hazards to young children, design the safest anesthetic and sedative regimes, and potentially foster the development of new practice guidelines and anesthetic drugs.
Dr. Lena S. Sun, E.M. Papper Professor of Pediatric Anesthesiology, Professor of Anesthesiology & Pediatrics and Chief of Division of Pediatric Anesthesiology at Columbia University Medical Center, leads the effort as the Principal Investigator of the multi-site PANDA (Pediatric Anesthesia and Neuro-Development Assessment) study to pursue the important research question of whether anesthetic exposure has detrimental effects in the developing human brain. SmartTots funding will support the completion of this ongoing study on the effects of a single episode of early childhood anesthesia exposure before age 3 years on long-term neurocognitive function and behavior in healthy children. The PANDA study will provide the first set of neurocognitive and behavior data in healthy children that are prospectively collected and directly assessed. The study is expected to provide the needed evidence for informed discussions with providers and parents as well as guidance for clinical decision-making.
"As a practicing pediatric anesthesiologist, I am able to provide the clinical perspective and context to the important issue of anesthetic neurotoxicity in the developing human brain," shared Dr. Sun. "This funding will allow us to complete a very important research project that will provide some of the critically important evidence related to anesthesia and neurodevelopment, in healthy children having elective procedures."
Dr. Jeffrey Sall, Hamilton Associate Professor at UCSF School of Medicine, Department of Anesthesia and Perioperative Care, will be utilizing the SmartTots grant funding to study the limits or boundary conditions of early childhood anesthesia exposure that lead to cognitive deficits. This project will determine how the duration of anesthesia exposure and the age of the child at the time of exposure affect recognition memory deficits. The results of this study will provide guidance to clinicians and parents when deciding to perform certain procedures and will give future researchers an important outcome measure that is easily testable.
"As a neuroscientist and neuro and obstetric anesthesiologist, I have established a laboratory focused on how anesthetics impact the developing brain and effect learning and behavior," explained Dr. Sall. "The funding from SmartTots will allow us to extend our findings from rodent behavior studies and a preliminary human trial. We will examine recognition memory in children and determine what the anesthetic exposure limits are that may lead to a deficit."
SmartTots research grants were made possible thanks to generous contributions by individual donors and foundations, as well as a contribution from the International Anesthesia Research Society (IARS). The IARS and SmartTots are dedicated to funding research needed to determine the safety of anesthetics and ensure the safest treatments are available for children.
New research sheds light on how GLP-1 obesity drugs may change food cravings